首页> Endocrine reviews> Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

导出 OA

翻译打印收藏纠错

第一作者： Qiwei,Yang

第一单位： Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.

作者： Qiwei,Yang ^[1] ; Michal,Ciebiera ^[2] ; Maria Victoria,Bariani ^[1] ; Mohamed,Ali ^[3] ; Hoda,Elkafas ^[4] ; Thomas G,Boyer ^[5] ; Ayman,Al-Hendy ^[1]

作者单位： Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA. ^[1] Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, ul. Cegłowska 80, 01-809, Warsaw, Poland. ^[2] Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt. ^[3] Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL 60612, USA.;Department of Pharmacology and Toxicology, Egyptian Drug Authority, formerly National Organization for Drug Control and Research, Cairo 35521, Egypt. ^[4] Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA. ^[5]

关键词 developmental origin epigenetics pathways future directions genetic instability novel treatment reprogramming uterine fibroids

医学主题词女(雌)性(Female);人类(Humans);平滑肌瘤(Leiomyoma);子宫肌层(Myometrium);危险因素(Risk Factors);子宫肿瘤(Uterine Neoplasms)

DOI 10.1210/endrev/bnab039

PMID 34741454

发布时间 2023-03-21

基金项目

R01 ES028615/ES/NIEHS NIH HHS/United States R01 HD094380/HD/NICHD NIH HHS/United States U54 MD007602/MD/NIMHD NIH HHS/United States R01 HD087417/HD/NICHD NIH HHS/United States R01 HD106285/HD/NICHD NIH HHS/United States R01 HD094378/HD/NICHD NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交